Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Cyclacel Pharmaceuticals Inc. (CYCC)

4.53   -0.05 (-1.09%) 07-02 16:00
Open: 4.57 Pre. Close: 4.58
High: 4.57 Low: 4.49
Volume: 210,363 Market Cap: 22M
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's oncology development programs include CYC065, a cyclin dependent kinase Inhibitors (CDK) that is in Phase I clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-like kinase inhibitor program, which is in Phase I clinical trial for the treatment of advanced leukemias. Its oncology development programs also comprise sapacitabine, an oral nucleoside analogue prodrug that is in Phase 1/2 combination study with seliciclib, a CDK inhibitor in patients with BRCA mutations; with olaparib, a poly ADP-ribose polymerase inhibitor in BRCA mutation positive patients with breast cancer; and Phase III clinical trial for the treatment of acute myeloid leukemia.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.572 - 4.603 4.603 - 4.628
Low: 4.431 - 4.461 4.461 - 4.486
Close: 4.486 - 4.535 4.535 - 4.575

Technical analysis

as of: 2020-07-02 4:29:02 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 5.80     One year: 6.27
Support: Support1: 4.32    Support2: 3.59
Resistance: Resistance1: 4.97    Resistance2: 5.37
Pivot: 4.60
Moving Average: MA(5): 4.59     MA(20): 4.68
MA(100): 7.04     MA(250): 9.07
MACD: MACD(12,26): -0.10     Signal(9): -0.12
Stochastic oscillator: %K(14,3): 39.34     %D(3): 36.94
RSI: RSI(14): 44.28
52-week: High: 19.60  Low: 3.85  Change(%): -60.9
Average Vol(K): 3-Month: 97102  10-Days: 26514

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CYCC has closed above bottom band by 29.4%. Bollinger Bands are 88.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to CYCC's normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sat, 27 Jun 2020
Active US Stocks in the Spotlight: Citigroup Inc (NYSE:C), KaloBios Pharmaceuticals Inc (NASDAQ:KBIO), Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) - Stocks Newswire

Mon, 22 Jun 2020
17 Healthcare Stocks Moving In Monday's Pre-Market Session - Benzinga

Thu, 18 Jun 2020
Where Does Wall Street Think Cyclacel Pharmaceuticals Inc (CYCC) Stock Will Go? - InvestorsObserver

Tue, 09 Jun 2020
Edited Transcript of CYCC earnings conference call or presentation 12-May-20 8:30pm GMT - Yahoo Finance

Thu, 04 Jun 2020
Cyclacel Pharmaceuticals Inc. (CYCC) 14-day ATR is 0.34: This Stock is Set to Soar Above its Peers - News Daemon

Tue, 12 May 2020
Cyclacel Pharmaceuticals Reports First Quarter 2020 Financial Results - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 5
Shares Float (M) 4
% Held by Insiders 5.32
% Held by Institutions 14.24
Shares Short (K) 220
Shares Short P. Month (K) 87

Stock Financials

EPS -8.609
EPS Est This Year -2.250
EPS Est Next Year -1.570
Book Value (p.s.) 12.080
Profit Margin
Operating Margin
Return on Assets (ttm) -35.9
Return on Equity (ttm) -51.6
Qtrly Rev. Growth
Gross Profit (p.s.) -0.959
Sales Per Share
EBITDA (p.s.) -2.033
Qtrly Earnings Growth
Operating Cash Flow (M) -9
Levered Free Cash Flow (M) -7

Stock Valuations

PE Ratio -0.53
PEG Ratio
Price to Book value 0.38
Price to Sales
Price to Cash Flow -2.57

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date 2016-07-31
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.